Physician profile
Daniel Ruggles
NPI 1609050202
$49,083.92
in general payments reported to CMS, 2019-2025
13 companies · $1,790 in 2025
The $1,790 reported for 2025 was more than what 80% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $9,153 · 2021: $300 · 2022: $10K · 2023: $9,128 · 2024: $1,193 · 2025: $1,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Food and Beverage: $1,165 · Honoraria: $500 · Travel and Lodging: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,317.92 |
| Food and Beverage | $1,165.18 |
| Honoraria | $500.00 |
| Travel and Lodging | $127.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive Specialized Orthopedics, INC. | $20,055.67 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Smith+Nephew, INC. | $18,609.19 | 2019-2022 | |
| Wishbone Medical INC. | $6,485.24 | 2022-2023 | Femoral Locking Plate System, Wishbone Mg, Blade Plate |
| Orthofix Medical, INC. | $1,837.70 | 2024-2025 | Fitbone, Tl-Hex Truelok Hexapod System |
| Medical Device Business Services, INC. | $762.68 | 2022 | |
| Curvafix, INC. | $551.82 | 2023-2024 | Curvafix Im Implant |
| Globus Medical, INC. | $309.38 | 2024-2025 | Precice® Intramedullary Limb Lengthening System, Precice Intramedullary Limb Lengthening System, A/R Femoral Nail |
| Orthopediatrics Corp. | $217.51 | 2024-2025 | |
| Biomarin Pharmaceutical INC. | $117.80 | 2024 | Voxzogo 1.2mg |
| Stryker Corporation | $75.14 | 2023 | T2 |
| Axogen | $29.77 | 2019 | |
| Kci USA, INC. | $16.05 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Bsn Medical INC | $15.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ruggles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.